Table 4.
Top 10 largest clusters of co-cited references.
| Cluster ID | Size | Silhouette | Mean Year | Top terms (LLR) |
|---|---|---|---|---|
| #0 | 23 | 0.986 | 2016 | Familial hypercholesterolemia; atherosclerosis |
| #1 | 21 | 1 | 2018 | Inclisiran |
| #2 | 17 | 0.977 | 1999 | Carotid arteries |
| #3 | 17 | 0.959 | 2000 | LDL receptor gene mutations |
| #4 | 17 | 0.941 | 2010 | Proprotein convertase subtilisin/kexin type 9 |
| #5 | 16 | 1 | 2002 | Risk factors |
| #6 | 16 | 0.986 | 2007 | Low-density lipoprotein receptor |
| #7 | 16 | 1 | 2013 | Evolocumab |
| #8 | 15 | 1 | 2001 | Lathosterol |
| #9 | 14 | 0.962 | 2015 | Alirocumab |
| #10 | 14 | 0.947 | 2003 | Narc-1 |
| #11 | 14 | 1 | 2011 | Survey |
| #12 | 14 | 0.904 | 2011 | Lomitapide |
| #13 | 14 | 0.91 | 2008 | Mutations |
| #14 | 14 | 0.979 | 2005 | LDL receptor |
| #15 | 10 | 1 | 2018 | Genetic analysis |
LDL = low-density lipoprotein, LLR = log-likelihood ratio, Narc-1 = neural apoptosis-regulated convertase.